<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01857258</url>
  </required_header>
  <id_info>
    <org_study_id>2013H0116</org_study_id>
    <nct_id>NCT01857258</nct_id>
  </id_info>
  <brief_title>Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction</brief_title>
  <official_title>Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to formulate and validate a green tea confection (i.e. &quot;gummy&quot;
      candy) as a strategy to attenuate postprandial hyperglycemia-induced impairments in vascular
      function. The central hypothesis is that a green tea confection will protect against vascular
      endothelial dysfunction by suppressing postprandial hyperglycemia. The central hypothesis of
      this application will be assessed by developing a green tea-containing confection, examining
      its physiochemical properties and its inhibition of starch digestion, and then validating its
      vasoprotective activities in healthy humans by assessing its blood glucose-regulating
      activities.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study involves validating a green tea confection (i.e. &quot;gummy&quot; candy) as a dietary
      strategy to attenuate postprandial hyperglycemia-induced impairments in vascular function.
      The central hypothesis is that a green tea confection will protect against vascular
      endothelial dysfunction by suppressing postprandial hyperglycemia. The central hypothesis of
      this application will be assessed by providing research participants 75 grams of carbohydrate
      in the form of a confection that contains no green tea concentrate or green tea concentrate
      at a level equivalent to approximately 3 cups of freshly brewed tea. Blood glucose and
      brachial artery flow-mediated dilation will be assessed at regular intervals during the 3
      hour postprandial period to define the extent to which green tea attenuates postprandial
      increases in blood glucose and decreases in vascular function that otherwise occur in a
      hyperglycemia-dependent manner.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area Under the Curve of Blood Glucose</measure>
    <time_frame>Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose</time_frame>
    <description>Blood glucose will be measured at 0, 30, 60, 90, 120, 150 and 180 minutes following the ingestion of a confection to calculate area under the concentration-time curve.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area Under the Curve of Brachial Artery Flow Mediated Dilatiion</measure>
    <time_frame>Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose</time_frame>
    <description>Brachial artery flow-mediated dilation will be measured at 0, 30, 60, 90, 120, 150, and 180 minutes following the ingestion of a confection.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brachial Artery Flow-mediated Dilation</measure>
    <time_frame>0 min (baseline)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Brachial Artery Flow-mediated Dilation</measure>
    <time_frame>60 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Malondialdehyde (0 Min)</measure>
    <time_frame>Baseline (0 min)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Malondialdehyde</measure>
    <time_frame>60 min postprandially</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of Asymmetric Dimethylarginine Relative to Arginine</measure>
    <time_frame>0 min (baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of Asymmetric Dimethylarginine Relative to Arginine</measure>
    <time_frame>60 min (baseline)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Hyperglycemia</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Green Tea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be provided a confection containing green tea concentrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be provided a confection devoid of green tea concentrate</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Green Tea Concentrate</intervention_name>
    <description>Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
    <arm_group_label>Green Tea</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Plasma glucose &lt;100 mg/dL

          -  Plasma total cholesterol &lt;200 mg/dL

          -  Plasma triglycerides &lt;140 mg/dL

          -  Blood pressure &lt;140/90

          -  non-dietary supplement user for &gt;2 months

          -  no use of medications known to affect carbohydrate metabolism,

          -  nonsmoker / never smoker

          -  no history of cardiovascular disease or gastrointestinal disorders

        Exclusion Criteria:

          -  allergies or aversions to green tea and/or corn starch,

          -  excessive alcohol consumption (&gt;3 drinks/d),

          -  &gt;5 h/wk of aerobic activity
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Bruno, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Sapper TN, Mah E, Ahn-Jarvis J, McDonald JD, Chitchumroonchokchai C, Reverri EJ, Vodovotz Y, Bruno RS. A green tea-containing starch confection increases plasma catechins without protecting against postprandial impairments in vascular function in normoglycemic adults. Food Funct. 2016 Sep 14;7(9):3843-53. doi: 10.1039/c6fo00639f. Epub 2016 Aug 5.</citation>
    <PMID>27494176</PMID>
  </results_reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2013</study_first_submitted>
  <study_first_submitted_qc>May 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2013</study_first_posted>
  <results_first_submitted>September 30, 2016</results_first_submitted>
  <results_first_submitted_qc>February 14, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">February 16, 2017</results_first_posted>
  <last_update_submitted>February 14, 2017</last_update_submitted>
  <last_update_submitted_qc>February 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Richard Bruno</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>green tea</keyword>
  <keyword>catechins</keyword>
  <keyword>vascular endothelial function</keyword>
  <keyword>postprandial hyperglycemia</keyword>
  <keyword>oxidative stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Green Tea First, Then Control</title>
          <description>Participants will be provided a confection containing green tea concentrate in fasting state one time. After a washout period of 7 days, they then will be provided a confection devoid of green tea concentrate in fasting state one time.
The green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose. The confection provides 50 grams of starch and 1 gram of green tea concentrate.</description>
        </group>
        <group group_id="P2">
          <title>Control First, Then Green Tea</title>
          <description>Participants will be provided a confection devoid of green tea concentrate in fasting state one time. After a washout period of 7 days, they then will be provided a confection containing green tea concentrate in fasting state one time.
The green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose. The confection provides 50 grams of starch and 1 gram of green tea concentrate.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (3 h Postprandially)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Wash-out Period (7 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (3 h Postprandially)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Baseline Participant Characteristics</title>
          <description>All participants completed both arms of the cross-over study</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.3" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.4" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting Glucose</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="88.9" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total Cholesterol</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="160.5" spread="21.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Area Under the Curve of Blood Glucose</title>
        <description>Blood glucose will be measured at 0, 30, 60, 90, 120, 150 and 180 minutes following the ingestion of a confection to calculate area under the concentration-time curve.</description>
        <time_frame>Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Green Tea</title>
            <description>Participants will be provided a confection containing green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Participants will be provided a confection devoid of green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Curve of Blood Glucose</title>
          <description>Blood glucose will be measured at 0, 30, 60, 90, 120, 150 and 180 minutes following the ingestion of a confection to calculate area under the concentration-time curve.</description>
          <units>mmol/L * min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="998" spread="29"/>
                    <measurement group_id="O2" value="981" spread="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Area Under the Curve of Brachial Artery Flow Mediated Dilatiion</title>
        <description>Brachial artery flow-mediated dilation will be measured at 0, 30, 60, 90, 120, 150, and 180 minutes following the ingestion of a confection.</description>
        <time_frame>Area under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Green Tea</title>
            <description>Participants will be provided a confection containing green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Participants will be provided a confection devoid of green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Curve of Brachial Artery Flow Mediated Dilatiion</title>
          <description>Brachial artery flow-mediated dilation will be measured at 0, 30, 60, 90, 120, 150, and 180 minutes following the ingestion of a confection.</description>
          <units>%FMD * min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="614" spread="65"/>
                    <measurement group_id="O2" value="653" spread="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Brachial Artery Flow-mediated Dilation</title>
        <time_frame>0 min (baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants will be provided a confection devoid of green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
          <group group_id="O2">
            <title>Green Tea</title>
            <description>Participants will be provided a confection containing green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
        </group_list>
        <measure>
          <title>Brachial Artery Flow-mediated Dilation</title>
          <units>% dilation</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.71" spread="0.42"/>
                    <measurement group_id="O2" value="3.54" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Brachial Artery Flow-mediated Dilation</title>
        <time_frame>60 min</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants will be provided a confection devoid of green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
          <group group_id="O2">
            <title>Green Tea</title>
            <description>Participants will be provided a confection containing green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
        </group_list>
        <measure>
          <title>Brachial Artery Flow-mediated Dilation</title>
          <units>% dilation</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.23" spread="0.44"/>
                    <measurement group_id="O2" value="3.04" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Malondialdehyde (0 Min)</title>
        <time_frame>Baseline (0 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Green Tea</title>
            <description>Participants will be provided a confection containing green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Participants will be provided a confection devoid of green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
        </group_list>
        <measure>
          <title>Malondialdehyde (0 Min)</title>
          <units>uM</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.18" spread="0.15"/>
                    <measurement group_id="O2" value="1.18" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Malondialdehyde</title>
        <time_frame>60 min postprandially</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Green Tea</title>
            <description>Participants will be provided a confection containing green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Participants will be provided a confection devoid of green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
        </group_list>
        <measure>
          <title>Malondialdehyde</title>
          <units>uM</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.44" spread="0.15"/>
                    <measurement group_id="O2" value="1.47" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio of Asymmetric Dimethylarginine Relative to Arginine</title>
        <time_frame>0 min (baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants will be provided a confection devoid of green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
          <group group_id="O2">
            <title>Green Tea</title>
            <description>Participants will be provided a confection containing green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio of Asymmetric Dimethylarginine Relative to Arginine</title>
          <units>nmol/umol</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.75" spread="0.26"/>
                    <measurement group_id="O2" value="6.24" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio of Asymmetric Dimethylarginine Relative to Arginine</title>
        <time_frame>60 min (baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Participants will be provided a confection devoid of green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
          <group group_id="O2">
            <title>Green Tea</title>
            <description>Participants will be provided a confection containing green tea concentrate
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio of Asymmetric Dimethylarginine Relative to Arginine</title>
          <units>nmol/umol</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.96" spread="0.51"/>
                    <measurement group_id="O2" value="7.18" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were monitored for any adverse events in response to ingesting starch-based confections containing no green tea or with green tea through study completion (9 days).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Green Tea, Then Control</title>
          <description>Participants will be provided a confection containing green tea concentrate in fasting state one time. After a washout period of 7 days, they then will be provided a confection devoid of green tea concentrate in fasting state one time.
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
        </group>
        <group group_id="E2">
          <title>Control, Then Green Tea</title>
          <description>Participants will be provided a confection devoid of green tea concentrate in fasting state one time. After a washout period of 7 days, they then will be provided a confection containing green tea concentrate in fasting state one time.
Green Tea Concentrate: Green tea concentrate is being examined as a dietary supplement that can regulate postprandial excursions in blood glucose</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This study was limited to normoglycemic adults who were healthy. Future studies may consider populations having glucose intolerance to examine the extent to which green tea attenuates starch-induced hyperglycemia.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Richard Bruno, PhD, RD</name_or_title>
      <organization>The Ohio State University</organization>
      <phone>6142925522</phone>
      <email>bruno.27@osu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

